Diagnosis:
Diabetic Mastopathy
• Diabetic mastopathy is associated with type 1 or type 2 diabetes mellitus and has been reported in nondiabetic patients as well.
• Inflammatory infiltrates are composed of lymphocytes with variable numbers of plasma cells. In addition, dense keloidal fibrosis that contains embedded epithelioid fibroblasts has been described.
• Core biopsy can be used to monitor patients with recurrent lesions in a proven case of diabetic mastopathy because it can show ductal epithelial cells in clusters, lymphocytes, and epithelioid fibroblasts.
• Epithelioid fibroblasts appear uniquely in diabetic mastopathy and are diagnostic when found, although they are not present in all cases.
• The pathophysiology of this condition is unclear, although the most widely postulated theory relates to the production of nonenzymatically glycosylated proteins in diabetes. These proteins are often cross-linked and resistant to degradation and are deposited within the matrix of various tissues, including the breast, where they can stimulate an immunogenic response.
• Most cases are reported in women, although a few cases have been reported in men, and an association with gynecomastia has been reported. It is widely reported that this condition occurs mainly in premenopausal women.
• Most mammograms of patients with diabetic mastopathy are reported with terms such as “dense breast parenchyma,” “dense glandular tissue,” “asymmetric densities,” and “parenchymal deformity.” A discrete mass lesion is typically not visualized.
Fong D, Lann MA, Finlayson C, et al:
Diabetic (lymphocytic) mastopathy with exuberant lymphohistiocytic and granulomatous response. Am J Surg Pathol 2006;30(10):1330-1336.
Thorncroft K, Forsyth L, Desmond S, et al:
The diagnosis and management of diabetic mastopathy. Breast J 2007;13(6):607-613.